Insulinoma surgery: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{{CMG}} {{Insulinoma}} ==Overview== The definitive management is surgical removal of the insulinoma. This may involve removing part of the pancreas as well ([[Whipple proced...") |
(Mahshid) |
||
| (37 intermediate revisions by 6 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Insulinoma}} | {{Insulinoma}} | ||
{{CMG}}; {{AE}}{{ADS}}, {{PSD}} | |||
==Overview== | |||
[[Surgery]] is the mainstay of treatment for insulinoma. It can be 80 to 100% curative in experienced surgical hands. The feasibility of surgery depends on the stage of insulinoma at diagnosis. | |||
==Surgery== | |||
Surgery is the mainstay of treatment for benign and resectable [[malignant]] insulinoma. It can be 80 to 100% curative in experienced surgical hands.<ref name="pmid23430217">{{cite journal| author=Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y et al.| title=Diagnosis and management of insulinoma. | journal=World J Gastroenterol | year= 2013 | volume= 19 | issue= 6 | pages= 829-37 | pmid=23430217 | doi=10.3748/wjg.v19.i6.829 | pmc=PMC3574879 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23430217 }} </ref><ref name="surgery">Inulinoma. national library of medicine. https://www.nlm.nih.gov/medlineplus/ency/article/000387.htm</ref> | |||
===Benign Tumors=== | |||
Small well-encapsulated, solitary tumors:<ref name="pmid23430217">{{cite journal| author=Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y et al.| title=Diagnosis and management of insulinoma. | journal=World J Gastroenterol | year= 2013 | volume= 19 | issue= 6 | pages= 829-37 | pmid=23430217 | doi=10.3748/wjg.v19.i6.829 | pmc=PMC3574879 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23430217 }} </ref><ref name="surgery">Inulinoma. national library of medicine. https://www.nlm.nih.gov/medlineplus/ency/article/000387.htm</ref><ref name="pmid1677058">{{cite journal| author=Service FJ, McMahon MM, O'Brien PC, Ballard DJ| title=Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study. | journal=Mayo Clin Proc | year= 1991 | volume= 66 | issue= 7 | pages= 711-9 | pmid=1677058 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1677058 }} </ref> | |||
*Tumors are localized with palpation in 70 % cases during surgery. Intra-operative ultrasound (IOUS) localizes in 86% of times. Palpation and IOUS together localize tumor in 83-98% cases.<ref name="pmid2829761">{{cite journal| author=Norton JA, Cromack DT, Shawker TH, Doppman JL, Comi R, Gorden P et al.| title=Intraoperative ultrasonographic localization of islet cell tumors. A prospective comparison to palpation. | journal=Ann Surg | year= 1988 | volume= 207 | issue= 2 | pages= 160-8 | pmid=2829761 | doi= | pmc=1493387 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2829761 }} </ref><ref name="pmid18156937">{{cite journal| author=Nikfarjam M, Warshaw AL, Axelrod L, Deshpande V, Thayer SP, Ferrone CR et al.| title=Improved contemporary surgical management of insulinomas: a 25-year experience at the Massachusetts General Hospital. | journal=Ann Surg | year= 2008 | volume= 247 | issue= 1 | pages= 165-72 | pmid=18156937 | doi=10.1097/SLA.0b013e31815792ed | pmc=3806046 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18156937 }} </ref> | |||
[[Image:Insulinoma.jpg|thumb|center|250px|Insulinoma. By Edward Alabraba et al. - Pancreatic insulinoma co-existing with gastric GIST in the absence of neurofibromatosis-1. World Journal of Surgical Oncology 2009, 7:18doi:10.1186/1477-7819-7-18, CC BY 2.0, https://commons.wikimedia.org/w/index.php?curid=6686376]] | |||
*[[Surgical resection]] is the treatment of choice. Minimal invasive surgery such as [[laparoscopic surgery]] is preferred especially for small and [[solitary]] [[benign]] insulinomas. | |||
:*[[Enucleation]] | |||
:*Partial [[pancreatectomy]] | |||
:*Distal [[pancreatectomy]] | |||
:*[[Pancreaticoduodenectomy]]<ref name="pmid15575328">{{cite journal| author=Vázquez Quintana E| title=The surgical management of insulinoma. | journal=Bol Asoc Med P R | year= 2004 | volume= 96 | issue= 1 | pages= 33-8 | pmid=15575328 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15575328 }} </ref> | |||
*Multiple, unencapsulated, > 4 cm in diameter, and involves or is near the main [[pancreatic duct]]: | |||
:*Radical resection | |||
*Insulinomas which are associated with [[MEN1]], excision of [[tumor]] found in the head of the [[pancreas]] plus a distal subtotal [[pancreatectomy]] is recommended.<ref name="pmid1684067">{{cite journal| author=Demeure MJ, Klonoff DC, Karam JH, Duh QY, Clark OH| title=Insulinomas associated with multiple endocrine neoplasia type I: the need for a different surgical approach. | journal=Surgery | year= 1991 | volume= 110 | issue= 6 | pages= 998-1004; discussion 1004-5 | pmid=1684067 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1684067 }} </ref> | |||
*For occult insulinomas, blind distal [[pancreatectomy]] is not advisable. <ref name="pmid12081066">{{cite journal| author=Hirshberg B, Libutti SK, Alexander HR, Bartlett DL, Cochran C, Livi A et al.| title=Blind distal pancreatectomy for occult insulinoma, an inadvisable procedure. | journal=J Am Coll Surg | year= 2002 | volume= 194 | issue= 6 | pages= 761-4 | pmid=12081066 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12081066 }} </ref> | |||
===Malignant Tumors=== | |||
*Resectable [[tumors]]:<ref name="pmid23430217">{{cite journal| author=Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y et al.| title=Diagnosis and management of insulinoma. | journal=World J Gastroenterol | year= 2013 | volume= 19 | issue= 6 | pages= 829-37 | pmid=23430217 | doi=10.3748/wjg.v19.i6.829 | pmc=PMC3574879 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23430217 }} </ref><ref name="surgery">Inulinoma. national library of medicine. https://www.nlm.nih.gov/medlineplus/ency/article/000387.htm</ref><ref name="pmid1677058">{{cite journal| author=Service FJ, McMahon MM, O'Brien PC, Ballard DJ| title=Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study. | journal=Mayo Clin Proc | year= 1991 | volume= 66 | issue= 7 | pages= 711-9 | pmid=1677058 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1677058 }} </ref> | |||
:*Aggressive surgical resection, including extended [[pancreatic]] resection with [[lymph nodes]], [[liver resection]], and/or [[liver transplantation]] | |||
:*Post-surgical [[chemoembolization]] or [[radiofrequency ablation]] of [[tumors]] to control [[hypoglycemia]]. | |||
*Unresectable [[tumors]] | |||
:*[[Octreotide]] administration | |||
:*Continuous [[glucose]] monitoring | |||
:*[[Radiofrequency ablation]] | |||
:*[[Embolization]] | |||
:*Intra-arterial [[chemotherapy]] | |||
== | ==Indications== | ||
* Repeated and prolonged symptoms of [[hypoglycemia]] | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Medicine]] | |||
[[Category:Endocrinology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Surgery]] | |||
Latest revision as of 02:07, 27 November 2017
|
Insulinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Insulinoma surgery On the Web |
|
American Roentgen Ray Society Images of Insulinoma surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2], Parminder Dhingra, M.D. [3]
Overview
Surgery is the mainstay of treatment for insulinoma. It can be 80 to 100% curative in experienced surgical hands. The feasibility of surgery depends on the stage of insulinoma at diagnosis.
Surgery
Surgery is the mainstay of treatment for benign and resectable malignant insulinoma. It can be 80 to 100% curative in experienced surgical hands.[1][2]
Benign Tumors
Small well-encapsulated, solitary tumors:[1][2][3]
- Tumors are localized with palpation in 70 % cases during surgery. Intra-operative ultrasound (IOUS) localizes in 86% of times. Palpation and IOUS together localize tumor in 83-98% cases.[4][5]
- Surgical resection is the treatment of choice. Minimal invasive surgery such as laparoscopic surgery is preferred especially for small and solitary benign insulinomas.
- Enucleation
- Partial pancreatectomy
- Distal pancreatectomy
- Pancreaticoduodenectomy[6]
- Multiple, unencapsulated, > 4 cm in diameter, and involves or is near the main pancreatic duct:
- Radical resection
- Insulinomas which are associated with MEN1, excision of tumor found in the head of the pancreas plus a distal subtotal pancreatectomy is recommended.[7]
- For occult insulinomas, blind distal pancreatectomy is not advisable. [8]
Malignant Tumors
- Aggressive surgical resection, including extended pancreatic resection with lymph nodes, liver resection, and/or liver transplantation
- Post-surgical chemoembolization or radiofrequency ablation of tumors to control hypoglycemia.
- Unresectable tumors
- Octreotide administration
- Continuous glucose monitoring
- Radiofrequency ablation
- Embolization
- Intra-arterial chemotherapy
Indications
- Repeated and prolonged symptoms of hypoglycemia
References
- ↑ 1.0 1.1 1.2 Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y; et al. (2013). "Diagnosis and management of insulinoma". World J Gastroenterol. 19 (6): 829–37. doi:10.3748/wjg.v19.i6.829. PMC 3574879. PMID 23430217.
- ↑ 2.0 2.1 2.2 Inulinoma. national library of medicine. https://www.nlm.nih.gov/medlineplus/ency/article/000387.htm
- ↑ 3.0 3.1 Service FJ, McMahon MM, O'Brien PC, Ballard DJ (1991). "Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study". Mayo Clin Proc. 66 (7): 711–9. PMID 1677058.
- ↑ Norton JA, Cromack DT, Shawker TH, Doppman JL, Comi R, Gorden P; et al. (1988). "Intraoperative ultrasonographic localization of islet cell tumors. A prospective comparison to palpation". Ann Surg. 207 (2): 160–8. PMC 1493387. PMID 2829761.
- ↑ Nikfarjam M, Warshaw AL, Axelrod L, Deshpande V, Thayer SP, Ferrone CR; et al. (2008). "Improved contemporary surgical management of insulinomas: a 25-year experience at the Massachusetts General Hospital". Ann Surg. 247 (1): 165–72. doi:10.1097/SLA.0b013e31815792ed. PMC 3806046. PMID 18156937.
- ↑ Vázquez Quintana E (2004). "The surgical management of insulinoma". Bol Asoc Med P R. 96 (1): 33–8. PMID 15575328.
- ↑ Demeure MJ, Klonoff DC, Karam JH, Duh QY, Clark OH (1991). "Insulinomas associated with multiple endocrine neoplasia type I: the need for a different surgical approach". Surgery. 110 (6): 998–1004, discussion 1004-5. PMID 1684067.
- ↑ Hirshberg B, Libutti SK, Alexander HR, Bartlett DL, Cochran C, Livi A; et al. (2002). "Blind distal pancreatectomy for occult insulinoma, an inadvisable procedure". J Am Coll Surg. 194 (6): 761–4. PMID 12081066.